3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Pancreatic Neoplasms
50
Colorectal Neoplasms
39
Stomach Neoplasms
27
Carcinoma, Hepatocellular
26
Ovarian Neoplasms
25
Melanoma
21
Breast Neoplasms
20
Carcinoma, Non-Small-Cell Lung
19
Neoplasms
15
Neoplasm Metastasis
15
Colonic Neoplasms
14
Esophageal Neoplasms
13
Uterine Cervical Neoplasms
11
Sarcoma
10
Liver Neoplasms
10
Carcinoma, Renal Cell
10
Lung Neoplasms
9
Anus Neoplasms
9
Rectal Neoplasms
8
Head and Neck Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Osteosarcoma
7
Triple Negative Breast Neoplasms
6
Mesothelioma
6
Hepatoblastoma
6
Gastrointestinal Neoplasms
6
Carcinoma
6
Adenocarcinoma
6
Vaginal Neoplasms
5
Small Cell Lung Carcinoma
5
Interventions
Specimen Handling
4
Magnetic Resonance Spectroscopy
3
Nivolumab
2
Biopsy
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
ribociclib
1
pembrolizumab
1
ceralasertib
1
belinostat
1
X-Rays
1
Tissue Banks
1
Ipilimumab
1
Immunoglobulin G
1
Fulvestrant
1
Fluorouracil
1
Cyclophosphamide
1
Colony-Stimulating Factors
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinosarcoma
×
Cyclophosphamide
×
Gastrointestinal
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled